Shenzhen Edge Medical Co., Ltd. (HKG:2675)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
35.70
-2.06 (-5.46%)
Sep 10, 2026, 4:08 PM HKT

Shenzhen Edge Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Strong Buy" and an average price target of $72.00. The average 1-year stock price forecast is 101.68% higher than the current stock price, while the lowest is $56.11 (+57.17%) and the highest is $99.28 (+178.10%).

Price Target: $72.00 (+101.68%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$56.11$72.00$69.41$99.28
Change+57.17%+101.68%+94.43%+178.10%
* Price targets were last updated on Aug 12, 2026.

Analyst Ratings

The average analyst rating for Shenzhen Edge Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Apr '26May '26Jul '26Aug '26
Strong Buy01233
Buy12222
Hold00000
Sell00000
Strong Sell00000
Total13455

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
DBS
DBS
Buy
Maintains
n/a
BuyMaintainsn/an/aAug 31, 2026
Unknown Analyst
Huachuang Securities
No rating
Huachuang Securities
Buy
Maintains
$74.00
BuyMaintains$74.00+107.28%Aug 12, 2026
Unknown Analyst
Morgan Stanley
No rating
Morgan Stanley
Buy
Maintains
$75.00
BuyMaintains$75.00+110.08%Jul 3, 2026
Goldman Sachs
Goldman Sachs
Buy
Initiates
$81.00
BuyInitiates$81.00+126.89%Apr 22, 2026
Unknown Analyst
GF Securities
No rating
GF Securities
Buy
Maintains
$73.85
BuyMaintains$73.85+106.86%Apr 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
846.20M
from 455.72M
Increased by 85.69%
Revenue Next Year
1.38B
from 846.20M
Increased by 62.90%
EPS This Year
0.24
from -0.06
EPS Next Year
0.56
from 0.24
Increased by 133.72%
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
48.04M159.99M455.72M846.20M
Revenue Growth
-233.03%184.83%85.69%
Gross Profit
4.56M98.08M300.65M518.72M
Gross Margin
9.49%61.30%65.97%61.30%
Operating Income
-267.44M-283.04M-117.31M154.15M
Net Income
-212.87M-218.51M-88.61M18.00M
EPS
---0.060.24
Forward PE
---127.93
Free Cash Flow
--159.70M-192.60M-120.00M
No. Analysts
---3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High852.2M
Avg846.2M
Low843.0M

Revenue Growth

Revenue Growth202620272028
High
87.0%
Avg
85.7%
Low
85.0%

EPS Forecast

EPS202620272028
High0.25
Avg0.24
Low0.23

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-